Infertility female

7 trials 1 recruiting MedDRA PT
7 Registered trials
1 Recruiting
7 Unique sponsors
6 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
A Gastroenterology (ATC A) 1
G Urology/Gynaecology (ATC G) 3
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 5 substances
Gonadotropin / pituitary hormone 1 substance
Phase II: 1 Phase IV: 3 Phase I: 1 Phase I (Other): 1 Other: 1

Filter these 7 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 7 trials

Phase II

1 trial
  • Medical University Of Bialystok Academic
    METFORMIN HYDROCHLORIDE
    2024-518670-13-00 1 country 2024 n=180
    Recruiting

Phase IV

3 trials
  • Santiago Dexeus Font Fundacio Privada Academic
    FOLLITROPIN DELTA; MENOTROPHIN; PROGESTERONE; TRIPTORELIN
    2025-524761-25-00 1 country n=240
    Pending
  • Universitair Medisch Centrum Utrecht Academic
    PROGESTERONE, MICRONISED
    2026-525747-33-00 1 country n=640
    Pending
  • University Medical Center Utrecht Academic
    PROGESTERONE, MICRONISED
    2022-501534-33-00 1 country 2023 n=1,008
    Ended

Phase I

1 trial

Phase I (Other)

1 trial
  • Merck Healthcare KGaA Commercial
    IMP not specified
    2023-507066-91-00 1 country 2024 n=14
    Ended

Other

1 trial
  • Xentria Inc. Commercial
    IMP not specified
    2025-523368-19-00 1 country n=48
    Not authorised
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Igyxos Commercial 1 Phase I 0
Xentria Inc. Commercial 1 Other 0
Merck Healthcare KGaA Commercial 1 Phase I (Other) 0
Medical University Of Bialystok Academic 1 Phase II 1
Santiago Dexeus Font Fundacio Privada Academic 1 Phase IV 0
Universitair Medisch Centrum Utrecht Academic 1 Phase IV 0
University Medical Center Utrecht Academic 1 Phase IV 0
New trials by year
2023
2
2024
2
← All indication landscapes